CBDA Research
5-HT1A: nausea
MB-231: Breast Cancer
MB-231: Breast Cancer
Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation
MB-231: Breast Cancer
MB-231: Breast Cancer
MB-231: Breast Cancer
Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration
Cancer, COx2, PPAR
MB-231: Breast Cancer
Cancer, COx2, PPAR
Cannabidiolic acid dampens the expression of cyclooxygenase-2 in MDA-MB-231 breast cancer cells: Possible implication of the peroxisome proliferator-activated receptor β/δ abrogation
COX2: Inflammation
COX2: Inflammation
Cancer, COx2, PPAR
Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis
dual PPAR agonists
COX2: Inflammation
dual PPAR agonists
Identification and characterization of phytocannabinoids as novel dual PPARα/γ agonists by a computational and in vitro experimental approach
TRP channels
COX2: Inflammation
dual PPAR agonists
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on
TRP channels and endocannabinoid metabolic enzymes
Rett syndrome
Rett syndrome
Rett syndrome
Chronic treatment with cannabidiolic acid (CBDA) reduces thermal pain sensitivity in male mice and rescues the hyperalgesia in a mouse model of Rett syndrome
Copyright © 2020 NeXtraction - All Rights Reserved.
Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
This website is not intended to provide medical information and does not claim to cure or treat any disease. Always speak to your doctor about health concerns.
Powered by GoDaddy
Did you receive our lotion sample?
Yes? Awesome! Do you have two minutes to let us know what you think about our topical formulation? To receive a sample, please request using our Contact Us page.